Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
St. Jude Children's Research Hospital
Secondary objectives of this protocol include the following:
* To describe the toxicities of defibrotide in patients with VOD.
* To describe the response rate of VOD in patients receiving defibrotide.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with clinical or pathologic diagnosis of veno-occlusive disease. The following criteria will be used:
1. Hyperbilirubinemia (greater than or equal to 2mg/dl) and two of the following: (hepatomegaly, ascites, or weight gain \[greater than or equal to 5% of baseline\]); OR,
2. Patient who do not fulfill criteria in #1 but who have pathologic or radiographic evidence of VOD.
